Fundación Gecp
Clinical trials sponsored by Fundación Gecp, explained in plain language.
-
New hope for mesothelioma patients: experimental drug tested in 47-person trial
Disease control CompletedThis phase II trial tested a drug called Bintrafusp alfa (M7824) in 47 people with advanced pleural mesothelioma that had worsened after platinum-based chemotherapy. The drug aims to block two proteins that help tumors grow. Researchers measured how long patients lived without th…
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New drug combo shows promise for tough lung cancer
Disease control CompletedThis study tested a combination of two drugs, atezolizumab and bevacizumab, as the first treatment for people with advanced non-squamous lung cancer that has a high number of genetic mutations. The goal was to see if this drug pair could slow down cancer growth. The trial enrolle…
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Lung cancer & COVID: new study tracks immune response in nearly 2,000 patients
Knowledge-focused CompletedThis study looked at nearly 2,000 adults with lung cancer who caught COVID-19. Researchers tracked their health and checked for antibodies (immune system markers) right after infection and again 6 months after vaccination. The goal was to understand how lung cancer affects the bo…
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Lung cancer study sheds light on hidden sexual struggles
Knowledge-focused CompletedThis study looked at sexual problems in 553 adults with lung cancer. Researchers wanted to find out how common these issues are and how severe they can be. The goal is to help doctors better support patients during and after cancer treatment.
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC